PetIQ, Inc. (NASDAQ:PETQ) – Investment analysts at Jefferies Group lifted their FY2017 earnings estimates for PetIQ in a report issued on Monday. Jefferies Group analyst K. Grundy now forecasts that the company will post earnings of $0.77 per share for the year, up from their previous estimate of $0.76. Jefferies Group has a “Buy” rating and a $26.00 price target on the stock.

A number of other equities analysts also recently weighed in on the stock. CIBC began coverage on shares of PetIQ in a research note on Tuesday, August 15th. They set an “outperform” rating and a $28.00 target price for the company. Raymond James Financial, Inc. started coverage on shares of PetIQ in a research note on Tuesday, August 15th. They set an “outperform” rating and a $26.00 target price for the company. Oppenheimer Holdings, Inc. started coverage on shares of PetIQ in a research note on Tuesday, August 15th. They issued an “outperform” rating and a $28.00 price target for the company. SunTrust Banks, Inc. started coverage on shares of PetIQ in a research note on Tuesday, August 15th. They issued a “buy” rating and a $28.00 price target for the company. Finally, William Blair started coverage on shares of PetIQ in a research note on Tuesday, August 15th. They issued an “outperform” rating for the company. Six analysts have rated the stock with a buy rating, PetIQ currently has an average rating of “Buy” and an average target price of $27.20.

COPYRIGHT VIOLATION NOTICE: “FY2017 Earnings Forecast for PetIQ, Inc. (PETQ) Issued By Jefferies Group” was published by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/11/21/fy2017-earnings-forecast-for-petiq-inc-petq-issued-by-jefferies-group.html.

PetIQ (PETQ) opened at $22.20 on Tuesday. PetIQ has a 52 week low of $17.03 and a 52 week high of $28.23. The company has a quick ratio of 4.67, a current ratio of 6.83 and a debt-to-equity ratio of 0.19.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Eos Management L.P. bought a new stake in PetIQ in the third quarter valued at $143,836,000. Wasatch Advisors Inc. bought a new stake in PetIQ in the third quarter valued at $7,229,000. Cortina Asset Management LLC bought a new stake in PetIQ in the third quarter valued at $5,956,000. Pier Capital LLC bought a new stake in PetIQ in the third quarter valued at $5,842,000. Finally, Highbridge Capital Management LLC bought a new stake in PetIQ in the third quarter valued at $5,578,000. 34.94% of the stock is owned by hedge funds and other institutional investors.

About PetIQ

PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.

Earnings History and Estimates for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ Inc. and related companies with MarketBeat.com's FREE daily email newsletter.